• Markets
    • icon
  • Companies
ME1 · ASX

Melodiol Global Health Limited (ASX:ME1)

AU$0.002

 0.0 (0.0%)
ASX:Live
30/11/2023 04:10:33 PM
Volume Spike Near Support (Realtime) Near Support Near 52 Week Low HALO Ords +3
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

ME1 Overview

ME1 Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About ME1

Website

Melodiol Global Health Limited

Telephone

61.8.9389.3180

Address

Suite 5 CPC 145 Stirling Highway Nedlends, Western Australia (WA) 6009

Description

Melodiol Global Health Ltd. engages in the developing, register and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. It operates through the following geographical segments: Europe includes Creso Pharma Switzerland GmbH, Canada includes the operating companies; Mernova Medicinal Inc, Halucenex Life Sciences Inc., Creso Impactive Ltd, United States of America, and Creso Pharma Limited in Australia. The company was founded by Adam Blumenthal, Miri Halperin Wernli and Boaz Wachtel on November 20, 2015 and is headquartered in Nedlends, Australia.

ME1 Price Chart

Key Stats

Market Cap

AU$8.87M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.02

Trade Value (12mth)

AU$29,501.00

1 week

-33.33%

1 month

-33.33%

YTD

-90%

1 year

-89.47%

All time high

1.65

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

2180m

HALO Sector

Healthcare

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.04

ME1 Announcements

Latest Announcements

Date Announcements

31 October 23

Prospectus - Bonus Options

×

Prospectus - Bonus Options

31 October 23

Update - Proposed issue of securities - ME1

×

Update - Proposed issue of securities - ME1

31 October 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

31 July 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

31 July 23

Cancel - Proposed issue of securities - ME1

×

Cancel - Proposed issue of securities - ME1

31 August 23

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

31 August 23

Half Year Results Commentary

×

Half Year Results Commentary

30 October 23

Application for quotation of securities - ME1

×

Application for quotation of securities - ME1

30 June 23

Appendix 2A

×

Appendix 2A

30 June 23

Appendix 3G

×

Appendix 3G

29 November 23

Application for quotation of securities - ME1

×

Application for quotation of securities - ME1

28 August 23

Application for quotation of securities - ME1

×

Application for quotation of securities - ME1

27 October 23

Application for quotation of securities - ME1

×

Application for quotation of securities - ME1

27 October 23

Application for quotation of securities - ME1

×

Application for quotation of securities - ME1

27 October 23

Application for quotation of securities - ME1

×

Application for quotation of securities - ME1

27 October 23

Application for quotation of securities - ME1

×

Application for quotation of securities - ME1

27 October 23

Application for quotation of securities - ME1

×

Application for quotation of securities - ME1

27 October 23

Application for quotation of securities - ME1

×

Application for quotation of securities - ME1

27 October 23

Notification regarding unquoted securities - ME1

×

Notification regarding unquoted securities - ME1

27 October 23

Cleansing Notice

×

Cleansing Notice

27 October 23

Proposed issue of securities - ME1

×

Proposed issue of securities - ME1

27 October 23

Proposed issue of securities - ME1

×

Proposed issue of securities - ME1

27 November 23

Application for quotation of securities - ME1

×

Application for quotation of securities - ME1

26 October 23

Proposed issue of securities - ME1

×

Proposed issue of securities - ME1

26 October 23

Proposed issue of securities - ME1

×

Proposed issue of securities - ME1

26 October 23

Proposed issue of securities - ME1

×

Proposed issue of securities - ME1

26 October 23

Capital Raising & Corporate Update

×

Capital Raising & Corporate Update

26 October 23

Proposed issue of securities - ME1

×

Proposed issue of securities - ME1

ME1 Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
FCFPS $ Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
DPS $ Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
BPS $ Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Basic m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Income Statement
Sales $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Gross Income $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
EBITDA $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
EBIT $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Net Income $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Total Assets $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Net Debt $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Equity $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Invested Capital Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Equity % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Assets % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Equity % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.04%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

ME1 Shortsell

Frequently Asked Questions

The current share price of Melodiol Global Health Limited (ME1:ASX) is AU$0.002.
The 52-week high share price for Melodiol Global Health Limited (ME1:ASX) is AU$0.02.
The 52-week low share price for Melodiol Global Health Limited (ME1:ASX)? is AU$0.00.
Melodiol Global Health Limited (ME1:ASX) does not pay a dividend.
Melodiol Global Health Limited (ME1:ASX) does not pay a dividend.
Melodiol Global Health Limited (ME1:ASX) has a franking level of 0%.
Melodiol Global Health Limited (ME1:ASX) is classified in the Healthcare.
The current P/E ratio for Melodiol Global Health Limited (ME1:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.